These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8504217)

  • 1. Natural killer cells and the MHC class I pathway of peptide presentation.
    Kärre K
    Semin Immunol; 1993 Apr; 5(2):127-45. PubMed ID: 8504217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missing self recognition by natural killer cells in MHC class I transgenic mice. A 'receptor calibration' model for how effector cells adapt to self.
    Sentman CL; Olsson MY; Kärre K
    Semin Immunol; 1995 Apr; 7(2):109-19. PubMed ID: 7579193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cell recognition of MHC class I. NK cells are sensitive to peptide-binding groove and surface alpha-helical mutations that affect T cells.
    Kurago ZB; Smith KD; Lutz CT
    J Immunol; 1995 Mar; 154(6):2631-41. PubMed ID: 7876538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
    Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
    J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.
    Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG
    J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC gene control of the natural killer system at the level of the target and the host.
    Kärre K
    Semin Cancer Biol; 1991 Oct; 2(5):295-309. PubMed ID: 1773046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid resistance in vitro. Possible role of both class I MHC and self peptides in determining the level of target cell sensitivity.
    Chadwick BS; Miller RG
    J Immunol; 1992 Apr; 148(7):2307-13. PubMed ID: 1545133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human NK cell education by inhibitory receptors for MHC class I.
    Anfossi N; André P; Guia S; Falk CS; Roetynck S; Stewart CA; Breso V; Frassati C; Reviron D; Middleton D; Romagné F; Ugolini S; Vivier E
    Immunity; 2006 Aug; 25(2):331-42. PubMed ID: 16901727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of major histocompatibility complex class I free heavy chains and enhanced sensitivity to natural killer cells after incubation of human lymphoid lines with beta 2-microglobulin.
    Carbone E; Stuber G; Andrée S; Franksson L; Klein E; Beretta A; Siccardi AG; Kärre K
    Eur J Immunol; 1993 Aug; 23(8):1752-6. PubMed ID: 7688306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
    Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
    J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
    Kumar V; McNerney ME
    Nat Rev Immunol; 2005 May; 5(5):363-74. PubMed ID: 15841099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells.
    Reyburn HT; Mandelboim O; Valés-Gómez M; Davis DM; Pazmany L; Strominger JL
    Nature; 1997 Apr; 386(6624):514-7. PubMed ID: 9087413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1- mice.
    Dorfman JR; Zerrahn J; Coles MC; Raulet DH
    J Immunol; 1997 Dec; 159(11):5219-25. PubMed ID: 9548460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of major histocompatibility complex class I alpha 1/alpha 2 domain polymorphism and in vivo expression pattern in tumor resistance: studies with transgenic mice and lymphoma cell transfectants.
    Höglund P; Waldenström M; Kärre K
    J Immunother Emphasis Tumor Immunol; 1993 Oct; 14(3):175-81. PubMed ID: 8297899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of the natural killer cell repertoire: the sequential vs. the two-step selection model.
    Salmon-Divon M; Höglund P; Mehr R
    Bull Math Biol; 2003 Mar; 65(2):199-218. PubMed ID: 12675329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules.
    Johansson S; Johansson M; Rosmaraki E; Vahlne G; Mehr R; Salmon-Divon M; Lemonnier F; Kärre K; Höglund P
    J Exp Med; 2005 Apr; 201(7):1145-55. PubMed ID: 15809355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MHC class I molecule H-2Dp inhibits murine NK cells via the inhibitory receptor Ly49A.
    Olsson-Alheim MY; Sundbäck J; Kärre K; Sentman CL
    J Immunol; 1999 Jun; 162(12):7010-4. PubMed ID: 10358142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired immune responses and altered peptide repertoire in tapasin-deficient mice.
    Garbi N; Tan P; Diehl AD; Chambers BJ; Ljunggren HG; Momburg F; Hämmerling GJ
    Nat Immunol; 2000 Sep; 1(3):234-8. PubMed ID: 10973281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.